Mutual Funds Increase Exposure to Healthcare and Pharma Amid Market Volatility
3 hours agoBusiness
48LENS
2 SourcesIndia
TBNthebalanced.news

Mutual Funds Increase Exposure to Healthcare and Pharma Amid Market Volatility

Domestic mutual funds are increasing their exposure to healthcare and pharmaceutical stocks, with about 71% of fund houses running overweight positions compared to benchmarks. Healthcare accounted for 7.3% of total mutual fund portfolios in February 2026, ranking as the fourth-largest sector allocation. The Nifty Pharma index has outperformed the broader Nifty 50 during recent market volatility, supporting this trend. Some fund houses, including Invesco and HSBC, have notably higher allocations, while others remain close to benchmark weights.

Political Bias
0%100%0%
Sentiment
70%
21 stories available
View AI Analysis

Bias Analysis: The articles focus on financial data and market trends without political framing. They present perspectives from mutual fund trackers and industry experts, emphasizing investment strategies and sector performance. There is no evident political bias, as coverage centers on economic and market developments rather than political viewpoints.

Sentiment: The tone across the articles is generally neutral to positive, highlighting increased fund allocations to healthcare and pharma due to improved growth visibility and sector resilience. While acknowledging broader market volatility, the coverage emphasizes the relative strength of pharma stocks, reflecting cautious optimism among investors.

Lens Score: 48/100 — Story is receiving appropriate media attention. Public interest: 0/100. Coverage gap: 100%.